A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients
Introduction: Hyperphosphatemia in patients undergoing dialysis is not well-controlled. AP306 is a pan-inhibitor of phosphate transporters, designed to block the active uptake of phosphate through the gastrointestinal tract. Methods: In this phase 2 randomized, active-controlled, open-label study, h...
Saved in:
| Main Authors: | Li Wang, Li Zuo, Ming Shi, Leyi Gu, Kunling Ma, Pei Wang, Yu Wang, Qun Luo, Menghua Chen, Ping Zhang, Hongli Jiang, Guisen Li, Weifeng Zhang, Yingxue Cathy Liu, Qing Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925000634 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta analysis of efficiency and safety of sevelamer in the treatment of hyperphosphatemia in patients with maintenance hemodialysis
by: YANG Ling
Published: (2018-01-01) -
The influencing factors of phosphate control behavior among patients undergoing hemodialysis: based on the health belief model
by: Manman Gao, et al.
Published: (2025-12-01) -
Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden
by: Brunelle Bruna Scavello Coelho Ferezin, et al.
Published: (2025-01-01) -
A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients
by: Nicholas S. Kowalczyk, et al.
Published: (2025-05-01) -
The U-shaped association between initial serum phosphate level and mortality of traumatic brain injury patients
by: Ruoran Wang, et al.
Published: (2025-06-01)